Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Yanaprima Hastapersada Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Yanaprima Hastapersada Tbk diperdagangkan di Rp1.385 (kapitalisasi pasar 808,28 M, volume 24 jam 383,7 rb). Perbedaan utamanya: Yanaprima Hastapersada Tbk jauh lebih besar — sekitar 4,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Yanaprima Hastapersada Tbk lebih aktif diperdagangkan (383,7 rb vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | YPAS | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 808,28 M |
Volume | 324 rb | 383,7 rb |
Lot | 3,24 rb | 3,84 rb |
Perputaran | 77,68 jt | 504,87 jt |
Harga Rata-rata | 239,75 | 1.315,78 |
Nilai Transaksi | 77,68 jt | 504,87 jt |
Harga Ekuilibrium Indikatif | 240 | 1.385 |
Volume Ekuilibrium Indikatif | 1 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Selengkapnya di halaman YPAS →